logo

For the Inventor, By the Inventor

Homburg, Germany

Ozlem Tureci

This inventor holds 13 USPTO granted patents. Top assignees: Ludwig Institute for Cancer Research Limited, Cornell University, Memorial Sloan Kettering Cancer Center. Active years: 1999-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ozlem Tureci. Retrieved from https://idiyas.com/inventor/ozlem-tureci-h5p554f5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 84.6

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 67(Granted Patents)


Location History:

  • Saar, DE (2000)
  • Homburg/Saar, DE (1999 - 2008)

Company Filing History:

goldMedal12 out of 530 
 
Ludwig Institute for Cancer Research Limited
 patents
silverMedal1 out of 2,954 
 
Cornell University
 patents
bronzeMedal1 out of 621 
 
Memorial Sloan Kettering Cancer Center
 patents
4. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2008

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7385044 - Isolated peptides which bind to MHC Class II molecules, and uses thereof (2008-06-10),
2. 7270819 - Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof (2007-09-18),
3. 6800730 - Isolated peptides which bind to MHC class II molecules, and uses thereof (2004-10-05),
4. 6548064 - Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules (2003-04-15),
5. 6339140 - SSX family proteins (2002-01-15),
6. 6306389 - Isolated SCP proteins and uses thereof (2001-10-23),
7. 6291658 - Isolated nucleic acid molecules encoding SSX family members and thereof (2001-09-18),
8. 6274145 - Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof (2001-08-14),
9. 6261778 - Isolated nucleic acid molecules which encode SCP proteins, and uses thereof (2001-07-17),
10. 6214983 - Isolated nucleic acid molecules which encode SCP proteins (2001-04-10),
11. 6140050 - Methods for determining breast cancer and melanoma by assaying for a (2000-10-31),
12. 6069233 - Isolated nucleic acid molecule encoding an esophageal cancer associated (2000-05-30),
13. 5888751 - Method for diagnosis and treating cancers, and methods for identifying (1999-03-30),

Title: Inventor Ozlem Tureci: Pioneering Innovations in Homburg/Saar

Introduction: Ozlem Tureci is a renowned inventor based in Homburg/Saar, Germany, known for her groundbreaking contributions to the field of biotechnology and immunotherapy.

Latest Patents: Ozlem Tureci holds several patents related to novel cancer treatment methods and therapeutic vaccines, showcasing her commitment to advancing medical science through innovation.

Career Highlights: With a background in medicine and a focus on oncology, Ozlem Tureci co-founded a biotechnology company that has revolutionized cancer treatment through cutting-edge research and development.

Collaborations: Throughout her career, Ozlem Tureci has collaborated with leading scientists, researchers, and medical professionals to bring life-changing therapies to patients around the world.

Conclusion: Ozlem Tureci's dedication to innovation and her relentless pursuit of improving cancer care have solidified her reputation as a pioneering inventor in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…